SNNAQ (Sienna Biopharmaceuticals) Inventory Turnover: 0.00 (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Sienna Biopharmaceuticals Inventory Turnover?

Sienna Biopharmaceuticals SNNAQ -99.00% Inventory Turnover is 0.00 as of Sep. 2019.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Sienna Biopharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.00 Mil. Sienna Biopharmaceuticals's Average Total Inventories for the quarter that ended in Sep. 2019 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sienna Biopharmaceuticals's Days Inventory for the three months ended in Sep. 2019 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2019 )/Cost of Goods Sold (Q: Sep. 2019 )*Days in Period
=0/0*365 / 4
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sienna Biopharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2019 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Sienna Biopharmaceuticals Inventory Turnover Related Terms

Sienna Biopharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Inventory Turnover Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Inventory Turnover
0.00 0.00 0.00 0.00

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sienna Biopharmaceuticals Inventory Turnover Calculation

Sienna Biopharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2018 is calculated as

Inventory Turnover (A: Dec. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2018 ) / ((Total Inventories (A: Dec. 2017 ) + Total Inventories (A: Dec. 2018 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

Sienna Biopharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2019 is calculated as

Inventory Turnover (Q: Sep. 2019 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2019 ) / ((Total Inventories (Q: Jun. 2019 ) + Total Inventories (Q: Sep. 2019 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 0.00 mean?
Sienna Biopharmaceuticals (SNNAQ) has a Inventory Turnover of 0.00 as of Sep. 2019. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Inventory Turnover too high?
Sienna Biopharmaceuticals' current Inventory Turnover is 0.00.
How does Sienna Biopharmaceuticals' Inventory Turnover compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Inventory Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Biotechnology company?
A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Inventory Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Inventory Turnover of 0.00. The current Inventory Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Inventory Turnover is 0.00 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.